{"pageContent": "Purpose of review: The aim of this study was to summarize the latest evidence, as well as the rationale behind using focal therapy for the treatment of prostate cancer. With patients becoming more educated, knowledge of the available evidence is key when discussing treatment.", "metaData": {"source": "Retreatment of men with metastatic castrate-resistant prostate cancer with abiraterone\nhttps://pubmed.ncbi.nlm.nih.gov/25111736/"}}